Compare two kinds of Surfactant

Phase 3

• Conditions: Respiratory distress syndrom.; Respiratory distress syndrome of newborn; P22.0

• Registration Number: IRCT20210501051148N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

Preterm neonate
Respiratory distress syndrome

Exclusion Criteria

Congenital cardiac anomaly
Congenital gastrointestinal anomaly
Congenital urological anomaly
Chromosomal disorder

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement Respiratory distress syndrom. Timepoint: ?From beginning, Daily. Method of measurement: Physical examination.;Mortality. Timepoint: From birthing continuous to end of treatment. Method of measurement: Vital sign checking.;Patent dactus arteriosus. Timepoint: From birthing intermittent echo cardiography. Method of measurement: Echo cardiography.;Intra ventricular hemorrhage. Timepoint: From birthing intermittent brain sonography. Method of measurement: Brain sonography.;Pulmonary hemorrhage. Timepoint: Daily. Method of measurement: Physical examination.;Pneumothorax. Timepoint: Daily. Method of measurement: Physical examination and chest x-ray.;Sepsis. Timepoint: From birthing intermittent. Method of measurement: Blood culture.